{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Alectinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Alectinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Alectinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "alectinib",
    "trial_2_text": "Alectinib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Alectinib Supplement: 60 participants will take Alectinib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Alectinib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Alectinib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.341439813375473,
      "64": 0.26523804664611816,
      "189": 0.2592054605484009,
      "78": 0.25293439626693726,
      "188": 0.2217462956905365,
      "173": 0.20850734412670135,
      "123": 0.20349876582622528,
      "21": 0.1589398831129074,
      "17": 0.14575199782848358,
      "9": 0.14414596557617188,
      "46": 0.1334540694952011,
      "20": 0.1334075629711151,
      "228": 0.1318790763616562,
      "136": 0.1279781013727188,
      "67": 0.1269131600856781,
      "49": 0.12196896970272064,
      "77": 0.12174580246210098,
      "131": 0.12050911784172058,
      "177": 0.12032201141119003,
      "37": 0.11616184562444687,
      "261": 0.1112956777215004,
      "211": 0.11046011745929718,
      "68": 0.1062396690249443,
      "191": 0.09749448299407959,
      "79": 0.09677740186452866,
      "101": 0.09548524767160416,
      "396": 0.09490722417831421,
      "104": 0.09091015160083771,
      "200": 0.08597388118505478,
      "14": 0.08526179939508438,
      "29": 0.08418548852205276,
      "30": 0.08329585194587708,
      "126": 0.0827232077717781,
      "38": 0.08224694430828094,
      "243": 0.08010705560445786,
      "5": 0.07967815548181534,
      "114": 0.07941651344299316,
      "151": 0.07924894243478775,
      "85": 0.07882509380578995,
      "343": 0.07779322564601898,
      "239": 0.07515803724527359,
      "186": 0.07499787956476212,
      "61": 0.07140212506055832,
      "2": 0.07127641141414642,
      "422": 0.07094209641218185,
      "441": 0.07075133919715881,
      "350": 0.070301853120327,
      "130": 0.0688830316066742,
      "257": 0.06878195703029633,
      "179": 0.06794016808271408,
      "341": 0.06764236837625504,
      "116": 0.06746312975883484,
      "139": 0.06493551284074783,
      "76": 0.06478869915008545,
      "86": 0.06397448480129242,
      "204": 0.06361651420593262,
      "297": 0.06252378970384598,
      "99": 0.062385596334934235,
      "147": 0.062298353761434555,
      "356": 0.06167086958885193,
      "82": 0.058694057166576385,
      "4": 0.058562807738780975,
      "466": 0.058554280549287796,
      "193": 0.05838853493332863,
      "288": 0.05745302140712738,
      "454": 0.05710242688655853,
      "36": 0.056956470012664795,
      "269": 0.05677151307463646,
      "108": 0.0562547966837883,
      "102": 0.05519063398241997,
      "300": 0.054423656314611435,
      "249": 0.053794920444488525,
      "33": 0.05281006172299385,
      "28": 0.052753034979104996,
      "456": 0.05202821269631386,
      "180": 0.05199183523654938,
      "92": 0.05157500132918358,
      "35": 0.05129220709204674,
      "253": 0.05047829821705818,
      "18": 0.05040847882628441,
      "199": 0.049703728407621384,
      "72": 0.0495520643889904,
      "96": 0.048192862421274185,
      "138": 0.04740997776389122,
      "212": 0.047168049961328506,
      "286": 0.04686062037944794,
      "355": 0.0466691292822361,
      "221": 0.045960236340761185,
      "382": 0.045391328632831573,
      "27": 0.0449104867875576,
      "234": 0.04417791590094566,
      "371": 0.043504826724529266,
      "535": 0.04305078461766243,
      "69": 0.042955610901117325,
      "11": 0.042552072554826736,
      "124": 0.04160761460661888,
      "31": 0.04120280593633652,
      "342": 0.040964603424072266,
      "351": 0.04072650149464607,
      "83": 0.04058295488357544
    },
    "trial_2_ae": {
      "87": 0.341439813375473,
      "64": 0.26523804664611816,
      "189": 0.2592054605484009,
      "78": 0.25293439626693726,
      "188": 0.2217462956905365,
      "173": 0.20850734412670135,
      "123": 0.20349876582622528,
      "21": 0.1589398831129074,
      "17": 0.14575199782848358,
      "9": 0.14414596557617188,
      "46": 0.1334540694952011,
      "20": 0.1334075629711151,
      "228": 0.1318790763616562,
      "136": 0.1279781013727188,
      "67": 0.1269131600856781,
      "49": 0.12196896970272064,
      "77": 0.12174580246210098,
      "131": 0.12050911784172058,
      "177": 0.12032201141119003,
      "37": 0.11616184562444687,
      "261": 0.1112956777215004,
      "211": 0.11046011745929718,
      "68": 0.1062396690249443,
      "191": 0.09749448299407959,
      "79": 0.09677740186452866,
      "101": 0.09548524767160416,
      "396": 0.09490722417831421,
      "104": 0.09091015160083771,
      "200": 0.08597388118505478,
      "14": 0.08526179939508438,
      "29": 0.08418548852205276,
      "30": 0.08329585194587708,
      "126": 0.0827232077717781,
      "38": 0.08224694430828094,
      "243": 0.08010705560445786,
      "5": 0.07967815548181534,
      "114": 0.07941651344299316,
      "151": 0.07924894243478775,
      "85": 0.07882509380578995,
      "343": 0.07779322564601898,
      "239": 0.07515803724527359,
      "186": 0.07499787956476212,
      "61": 0.07140212506055832,
      "2": 0.07127641141414642,
      "422": 0.07094209641218185,
      "441": 0.07075133919715881,
      "350": 0.070301853120327,
      "130": 0.0688830316066742,
      "257": 0.06878195703029633,
      "179": 0.06794016808271408,
      "341": 0.06764236837625504,
      "116": 0.06746312975883484,
      "139": 0.06493551284074783,
      "76": 0.06478869915008545,
      "86": 0.06397448480129242,
      "204": 0.06361651420593262,
      "297": 0.06252378970384598,
      "99": 0.062385596334934235,
      "147": 0.062298353761434555,
      "356": 0.06167086958885193,
      "82": 0.058694057166576385,
      "4": 0.058562807738780975,
      "466": 0.058554280549287796,
      "193": 0.05838853493332863,
      "288": 0.05745302140712738,
      "454": 0.05710242688655853,
      "36": 0.056956470012664795,
      "269": 0.05677151307463646,
      "108": 0.0562547966837883,
      "102": 0.05519063398241997,
      "300": 0.054423656314611435,
      "249": 0.053794920444488525,
      "33": 0.05281006172299385,
      "28": 0.052753034979104996,
      "456": 0.05202821269631386,
      "180": 0.05199183523654938,
      "92": 0.05157500132918358,
      "35": 0.05129220709204674,
      "253": 0.05047829821705818,
      "18": 0.05040847882628441,
      "199": 0.049703728407621384,
      "72": 0.0495520643889904,
      "96": 0.048192862421274185,
      "138": 0.04740997776389122,
      "212": 0.047168049961328506,
      "286": 0.04686062037944794,
      "355": 0.0466691292822361,
      "221": 0.045960236340761185,
      "382": 0.045391328632831573,
      "27": 0.0449104867875576,
      "234": 0.04417791590094566,
      "371": 0.043504826724529266,
      "535": 0.04305078461766243,
      "69": 0.042955610901117325,
      "11": 0.042552072554826736,
      "124": 0.04160761460661888,
      "31": 0.04120280593633652,
      "342": 0.040964603424072266,
      "351": 0.04072650149464607,
      "83": 0.04058295488357544
    }
  },
  "safety": {
    "trial_1_safety": 0.48497137427330017,
    "trial_2_safety": 0.48497137427330017
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47951486706733704
  }
}